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of CPa-1 in photosystem II
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Usinga combination of cyanogen bromide cleavage and endoproteinase digestion we have shown that the putative epitope for the mon~lonal
antibody FACZ lies in the region 3mPrcrlg1Ser on the apoprotein of CPa-1. This region lies entirely within the large extrinsic loop of this protein.
We have shown previously that the epitope of FAC2 becomes exposed in oxygen-evolving membranes upon treatment with alkaline Tris which
releases all four of the manganese associated with the oxygen-evolving site of photosystem II. The epitope is not exposed, however, after CaCI,
treatment and exposure to low concentrations of chloride, conditions which lead to the release of two of the four manganeses associated with
the oxygen-evolving site [(1987) Arch. B&hem. Biophys. 256,295-3011. These rest&s suggest that, upon release of the c~o~de-in~nsitive manganese from photosystem II membranes, a conformational change occurs which leads to the exposure of 360Pro-sg’Ser on CPa-1 to the monoclonal
antibody FACZ.
Photosystem II; Protein, CPa-1; Monoclonal antibody; Epitope mapping

1. INTRODUCTION
At least seven proteins appear to be required for
photosynthetic
oxygen evolution within the photosystem II (PS II) membrane protein complex [ 11. These
include the 47 kDa protein CPa-1 (CP47), the 45 kDa
protein CPa-2 (CP43), the 34 kDa Dl protein, the 32
kDa D2 protein, the extrinsic 33 kDa manganesestabilizing protein, and the 9 and 4.5 kDa subunits of
cytochrome b-559. Additionally, several low molecular
mass polypeptides have recently been identified which
appear to be associated with PS II [2]. At least one of
these, the 4.1 kDa product of the p&I gene, appears to
be associated with the PS II reaction center [3]. The
oxygen-evolving complex also contains a number of inorganic cofactors which are absolutely necessary for
water oxidation.
These cofactors
include bound
manganese, calcium and chloride [4-61. In vivo, the
proteins Dl, D2 and cytochrome b-559 may form the
reaction center of PS II and bear as prosthetic groups
the primary and secondary electron acceptors and
donors of the photosystem (YZ, P680, pheophytin, QA,
and, probably, QB). Dl-DZcytochrome
b-559 complexes have been isolated from both higher plants 17-91
and recently from cyanobacteria [ IO]. These complexes,
however, do not contain QA and cannot maintain a
stable charge separation. Additionally, this complex
does not contain bound manganese and is nonfunctional with respect to oxygen evolution. The proCorrespondence address: LX. Frankel, Department of Botany,
Louisiana State University, Baton Rouge, LA 70803, USA
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which bind the inorganic cofactors involved in oxygen evolution and the extrinsic 33 kDa protein have
not been unambiguously identified. Interestingly, all PS
II submembrane complexes which have been isolated to
date which have the ability to evolve oxygen contain the
two chlorophyll-proteins CPa-1 and CPa-2.
In a previous communication [l l] we described the
properties of the monoclonal antibody FAC2, which
recognized the chlorophyll-protein CPa-1. Interestingly, alkaline Tris-treatment, which removes the strongly
bound pool of manganese associated with the oxygenevolving site, increases the exposure of the antigenic
determinant of FAC2. In this communication we have
localized the putative antigenic determinant of the
monoclonal antibody FAC2 to a 32 amino acid residue
region located in the large extrinsic loop region of
CPa-1. These findings suggest that this region of CPa-1
may interact structurally with the PS II component(s)
responsible for manganese ligation.
teins
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2. MATERIALS

AND METHODS

A hybridoma cell line which secretes the monoclonal antibody
FAC2 was isolated after immuni~tion of BalbK mice with purified
PS II core I121as previously described [13,14]. The 49 kDa apoprotein
of CPa-1 was isolated by preparative electrophoresis of CaCla-washed
PS II oxygen-evolving membranes isolated by the procedure of
Ghanotakis and Babcock 1141using the buffer system of Delepelaire
and Chua 1151. 2.0 mg Chl of the CaCla-washed membranes were
separated on a 15% polyacrylamide gel with the dimensions 1.5 mm
X 12 cm x 14 cm. Electrophoresis conditions were 1.O W for 20 h at
4°C. The preparative gels were stained with acid-free Coomassie blue
(0.1% Coomassie brilliant blue in 25% MeOH) for 1 h and destained
with 25% MeGH. Cyanogen bromide (CNBr) treatment of the CPa-1
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apoprotein within gel fragments was carried out by the procedure of
Nikodem and Fresco [15] at a CNBr concentration of 55 mg/ml for
24 h. After CNBr cleavage, the peptide fragments were separated in
the electrophoretic system of Shagger and Von Jagow [17) which
clearly resolves peptides of low apparent molecular mass (I-30 kDa).
The 15.7 kDa CNBr fragment which bears the epitope of FAC2 (see
below) was excised from these gels after staining with acid-free
Coomassie blue as previously described, and electroeluted in a buffer
containing 0.025 M Tris, 0.19 M glycine, pH 8.3, and 0.1% lithium
dodecyl sulfate overnight at room temperature at 1 W. After electroelution, the 15.7 kDa peptide was transferred to a buffer containing 100 mM Tris-HCI, pH 6.8, and treated with 0.63 mg/ml carboxypeptidase Y (Sigma Chemical Co., catalog no. C-3888, lot no.
37F-8135) in the presence of freshly prepared phenylmethylsulfonyl
fluoride (PMSF) at a concentration of 5 mM for various times at
37°C. The resulting peptides were then electrophoresed in the low
molecular mass resolving gel system noted above. After electrophoresis, peptide fragments were transferred to Immobilon PVDF
membrane (Millipore Co.) by electroblotting and either stained with
acid-free Coomassie blue (destained with 50% MeOH), or blocked
with 5% non-fat dry milk in TS buffer (150 mM NaCl, 10 mM TrisHCl, pH 7.2). After blocking, the blots were then probed with FAC2
ascites fluid at a 1:2000 dilution in 1ToBSA in TS buffer overnight at
room temperature. The blots were then developed by incubation with
goat anti-mouse IgG + IgM-alkaline phosphatase conjugate (1:2000
dilution in 1% BSA in TS) and incubation with BCIP and NBT. For
sequencing, Coomassie blue stained bands were excised from the Immobilon and subjected to automated Edman degradation with either
an Applied Biosystems 470A or Porton PI 2090 sequencer.

3. RESULTS AND DISCUSSION
Fig.1 shows the results of CNBr cleavage of the
COOlTlClSSle
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apoprotein of CPa-1. With Coomassie blue staining,
nine major CNBr fragments ranging in apparent
molecular mass between 15.7 and 2 kDa are observed
(fig.1). Several other minor fragments are also visible
and are probably the result of incomplete cleavage.
Upon probing with the monoclonal antibody FAC2, a
single major CNBr fragment is observed with an apparent molecular mass of 15.7 kDa (fig.1). The Nterminal amino acid sequence of this peptide is PTFFE.
Examination of the derived amino acid sequence of the
spinach p&B gene which encodes CPa-1 [26] indicates
that the predicted CNBr fragment K (3~Pro-5a*Val)
contains this N-terminal sequence (see table 1). The
predicted mass of CNBr peptide K is 16.7 kDa which
corresponds well with the observed apparent molecular
mass. ~ydropathy
plot analysis [18] indicated that
CNBr peptide K (149 amino acid residues) contains
about L/zof the predicted large extrinsic loop of CPa-1
as well as the sixth transmembrane
helix and the
hydrophilic C-terminus of CPa-1 (see fig.3).
In an effort to define further the location of the antigenic determinant of FAC2, the 15.7 kDa CNBrpeptide was isolated by preparative eIectrophoresis,
electroeluted, and treated with a variety of proteolytic
enzymes (data not shown). The majority of these
treatments either destroyed the antigenic determinant
of FAC2 or produced large fragments of the 15.7 kDa
peptide which were of little use for further defining the
location of the antigenic determinant. Experiments with
carboxypeptidase Y purchased from Sigma Chemical
Co. (catalog no. C-3888, lot no. 37F-8135), however,
proved to be very interesting. Preliminary experiments
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Fig. 1, Western blot analysis of cyanogen bromide cleavage of CPa-1.
After cyanogen bromide treatment, electrophoresis and transfer to
Immobilon, lanes A (- CNBr) and B (+ CNBr) were either stained
with Coomassie blue or blocked and then probed with the monoclonal
antibody FACZ. A single major band at 15.7 kDa which binds the
monoclonal antibody is observed after cyanogen bromide treatment.

280

Fig.2. Western blot analysis of a timecourse of treatment of the
isolated 15.7 kDa cyanogen bromide fragment with Sigma carboxypeptidase Y (catalog no. C-3888, lot no. 37F-8135) in the presence of
5 mM PMSF. After enzyme treatment and electrophoresis, the proteins were transferred to Immobilon, blocked, and probed with the
monoclonal antibody FACZ. Lanes: A, 0 min incubation, no enzyme;
B, 0 min + enzyme; C, 15 min + enzyme; D, 30 min + enzyme; E, 60
min + enzyme. One major fragment was observed which bound the
monoclonal antibody FACZ. This is located at about 2 kDa.
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Table 1
Predicted cyanogen bromide fragments from the spinach p&B gene product [26] (CPa-1) and
sequences of isolated peptides bearing the epitope of the monoclonal antibody FAC2
Predicted cyanogen bromide fragments
Peptide

N-terminal sequence

A
B
C
D
E
F
G
H
I
J
K

2GLPWYRHTV.....25M
26HTALVAGWA.. . .“M
‘*ALYELAVFD.. .“M
s6WRQG60M
6’FV1PF66M
67TRLGITNSW.. . .lo2M
io3FSGLCFLAA . . . . .23’M
232GNIETVLSS... ..256M
257WYGSATTPI.....330M
33’DNGDGIAVG.....359M
3aPTFFETFPV.. . . .“‘V

Molecular mass (kDa)
2.1
1.2
2.0
0.7
0.7
3.8
14.1
2.5
8.5
3.3
16.7

Sequences of isolated peptides which bear the epitope of FAC2
Peptide

N-terminal sequence

15.7 kDa CNBr fragment

PTFFE

15.7

2kDa endoproteinase
fragment of 15.7 kDa peptide

PTFFETFPVVLIDGDGIVRADV

2.0

demonstrated that this carboxypeptidase Y preparation
was contaminated
with an unidentified,
PMSFinsensitive endoproteinase activity. Carboxypeptidase
Y obtained from Calbiochemical Co. did not exhibit
this endoproteolytic activity. The results obtained from
treating the 15.7 kDa CNBr fragment with Sigma carboxypeptidase Y in the presence of 5 mM PMSF are
shown in fig.2. A major fragment with an apparent

Apparent molecular mass (kDa)

molecular mass of 2.0 kDa was observed which reacted
with the monoclonal antibody FAC2. Upon extended
incubation (data not shown) the 2.0 kDa fragment was
further digested and could not be detected by either immunoprobing or Coomassie blue staining. N-terminal
sequencing of the 2.0 kDa fragment yields the following
sequence: PTFFETFPVVLIDGDGIVRADV,
which
corresponds to the N-terminal 22 amino acid residues of

Fig.3. Hydropathy plot of the predicted amino acid sequence [26] of thepsbB gene product, CPa-1. Rao-Argos membrane-spanning parameters
[18] were used and smoothed twice over a span of seven amino acid residues. Putative membrane-spanning alpha helixes are shown by roman
numerals I-VI. Hydrophilic regions which are predicted to be located on the lumenal side of the membrane by Von Heijne and Gavel analysis [25]
are shaded. The location of the large extrinsic loop region of CPa-1 is indicated. The location of the putative epitope of the monoclonal antibody
FAC2 is labeled and also indicated by the bold line. Both the N- and C-termini of this protein are predicted to be located on the stromal side of
the membrane.
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CNBr-peptide K. Because short peptides often migrate
anomalously in SDS-PAGE and because of the difficulties in sequencing short peptides (primarily loss of
sample Immobilon), we conservatively suggest that the
epitope for FAC2 lies within the N-terminal 32 amino
acid residues (360Pro-391Ser) of the N-terminus of the
CNBr peptide K and is located entirely in the large extrinsic loop region of CPa-1. These results have been
summarized in table 1.
Our results indicate that the putative epitope for the
monoclonal antibody FAC2 lies within the large extrinsic loop of the apoprotein of CPa-1. In an earlier study,
we had shown that this antibody not only recognizes
CPa-1 on ‘Western blots’ but also on PS II membranes
which had been attached to ELISA plates [I 11. We
observed that the accessibility of FAC2 to its antigenic
determinant was greatly increased by alkaline Tristreatment of PS II membranes. This treatment removes
the extrinsic 33 kDa manganese-stabilizing protein as
well as the four strongly bound manganeses associated
with the oxygen-evolving site of PS II. The antigenic
determinant was not exposed after CaClz treatment
followed by incubation of the PS II membranes in low
chloride buffer. This treatment removes the manganese-stabilizing protein and leads to a loss of two of the
four manganeses associated with the oxygen-evolving
site. We concluded that removal of the two chlorideinsensitive manganeses led to a conformational change
in components associated with PS II which influenced
the exposure of the antigenic determinant of FAC2 on
CPa-1. This conformational change leads to the exposure of the region 360Pro-391Ser on CPa-1. It is tempting to speculate on the nature of this conformational
change. Several lines of indirect evidence appear to indicate that the manganese associated with the oxygenevolving site is associated with the Dl and/or D2 proteins of the PS II reaction center [19,20]. Additionally,
results from our laboratory and others have strongly
suggested that CPa-1 is closely associated with the extrinsic manganese-stabilizing protein. The manganesestabilizing protein shields CPa-1 from tryptic attack
[ 111, the presence of the manganese-stabilizing protein
prevents labeling of lysyl residues on CPa-1 by NHSbiotin [21], and Cpa-1 can be crosslinked to the
manganese-stabilizing protein by a number of protein
crosslinkers ([21,22]; Edith Camm, personal communication). After crosslinking of CPa-1 with the
manganese-stabilizing
protein, the strongly bound
manganese is not released by alkaline pH treatment
[23]. We have suggested that CPa-1, in addition to its
role as an interior chlorophyll-a antenna protein for
PS II, may provide a binding site for the manganesestabilizing protein [21]. Additional binding sites may be
located on the Dl-D2-cytochrome b-559 complex [24].
With these data in mind, it is easy to imagine a model
in which release of the strongly bound manganese from
the PS II core leads to structural changes within the
282
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D 1-D2-cytochrome
b-599 complex. These changes
could lead to an increased exposure of 360Pro-39’Ser on
CPa-1 to the external environment. It should be noted
that no unequivocal evidence is available demonstrating
the ligation of manganese directly to the Dl-D2-cytochrome b-599 complex. If the manganese is associated
with other, as yet unidentified PS II components, then
conformational changes in these other proteins upon
manganese removal would lead to an exposure of the
antigenic determinant of FAC2 on CPa-1.
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